Transcription repression in oncogenic transformation: common targets of epigenetic repression in cells transformed by Fos, Ras or Dnmt1

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Oncogene

• Publication date

  2004-05-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1207483PMID 14990994
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting RAS signalling pathways in cancer therapy

  2003cited by this paper
• Molecular classification of familial non-BRCA1/BRCA2 breast cancer

  2003cited by this paper
• Chromosomal Instability and Tumors Promoted by DNA Hypomethylation

  2003cited by this paper
• Inhibition of DNA methylation and reactivation of silenced genes by zebularine.

  2003cited by this paper
• Methyl-CpG-binding Protein, MeCP2, Is a Target Molecule for Maintenance DNA Methyltransferase, Dnmt1*

  2003cited by this paper
• Induction of Tumors in Mice by Genomic Hypomethylation

  2003cited by this paper
• Mammalian RNAi for the masses.

  2003cited by this paper
• LOT1 (PLAGL1/ZAC1), the Candidate Tumor Suppressor Gene at Chromosome 6q24–25, Is Epigenetically Regulated in Cancer*

  2003cited by this paper
• The role of PML in tumor suppression.

  2002cited by this paper
• Cadherin and catenin alterations in human cancer

  2002cited by this paper
• The fundamental role of epigenetic events in cancer

  2002cited by this paper
• A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer

  2002cited by this paper
• Transcription factor fusions in acute leukemia: variations on a theme

  2002cited by this paper
• Methyltransferase Recruitment and DNA Hypermethylation of Target Promoters by an Oncogenic Transcription Factor

  2002cited by this paper
• Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling.

  2002cited by this paper
• RHO–GTPases and cancer

  2002cited by this paper
• 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy

  2002cited by this paper
• Gene silencing in mammals by small interfering RNAs

  2002cited by this paper
• Expression of a down-regulated target, SSeCKS, reverses v-Jun-induced transformation of 10T1/2 murine fibroblasts

  2001cited by this paper
• Alternative splicing of the imprinted candidate tumor suppressor gene ZAC regulates its antiproliferative and DNA binding activities

  2001cited by this paper
• Minimum information about a microarray experiment (MIAME)—toward standards for microarray data

  2001cited by this paper
• Characterization of the Methylation-sensitive Promoter of the Imprinted ZAC Gene Supports Its Role in Transient Neonatal Diabetes Mellitus*

  2001cited by this paper
• Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis

  2001cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Mouse Zac1, a Transcriptional Coactivator and Repressor for Nuclear Receptors

  2000cited by this paper
• Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

  2000cited by this paper
• DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters

  2000cited by this paper
• E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas.

  2000cited by this paper
• DNA methyltransferase Dnmt1 associates with histone deacetylase activity

  2000cited by this paper
• A genome-wide survey of RAS transformation targets

  2000cited by this paper
• Regulation of a multigenic invasion programme by the transcription factor, AP-1: re-expression of a down-regulated gene, TSC-36, inhibits invasion

  2000cited by this paper
• Smad1 and Smad4 Are Components of the Bone Morphogenetic Protein-4 (BMP-4)-induced Transcription Complex of the Xvent-2B Promoter*

  2000cited by this paper
• DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci

  2000cited by this paper
• SSeCKS, a Major Protein Kinase C Substrate with Tumor Suppressor Activity, Regulates G1→S Progression by Controlling the Expression and Cellular Compartmentalization of Cyclin D

  2000cited by this paper
• DNA hypermethylation in tumorigenesis: epigenetics joins genetics.

  2000cited by this paper
• Zac1 (Lot1), a Potential Tumor Suppressor Gene, and the Gene for ɛ-Sarcoglycan Are Maternally Imprinted Genes: Identification by a Subtractive Screen of Novel Uniparental Fibroblast Lines

  2000cited by this paper
• Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

  1999cited by this paper
• Role of DNA 5-methylcytosine transferase in cell transformation by fos.

  1999cited by this paper
• LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein

  1999cited by this paper
• Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.

  1999cited by this paper
• Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo.

  1999cited by this paper
• Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.

  1999cited by this paper
• BMP signalling in early Xenopus development

  1999cited by this paper
• hZAC encodes a zinc finger protein with antiproliferative properties and maps to a chromosomal region frequently lost in cancer.

  1998cited by this paper
• Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription

  1998cited by this paper
• Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex

  1998cited by this paper
• The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase.

  1997cited by this paper
• Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc finger protein expressed in the pituitary gland and the brain

  1997cited by this paper
• TGF-beta signalling from cell membrane to nucleus through SMAD proteins.

  1997cited by this paper
• TGF-β signalling from cell membrane to nucleus through SMAD proteins

  1997cited by this paper
• A Novel src- and ras-suppressed Protein Kinase C Substrate Associated with Cytoskeletal Architecture*

  1996cited by this paper
• Differential expression of elafin in human normal mammary epithelial cells and carcinomas is regulated at the transcriptional level.

  1995cited by this paper
• Isolation and characterization of a novel mitogenic regulatory gene, 322, which is transcriptionally suppressed in cells transformed by src and ras

  1995cited by this paper
• Regulation of DNA methylation by the Ras signaling pathway

  1995influential reference
• Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas.

  1995cited by this paper
• Cell transformation by c-fos requires an extended period of expression and is independent of the cell cycle

  1994cited by this paper
• Purification of CpG islands using a methylated DNA binding column

  1994cited by this paper
• Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells.

  1993cited by this paper
• Increased cytosine DNA-methyltransferase activity during colon cancer progression.

  1993cited by this paper
• Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA.

  1992cited by this paper
• High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer.

  1991cited by this paper
• Conversion of the lac repressor into an allosterically regulated transcriptional activator for mammalian cells

  1990cited by this paper
• Microinjection of transforming ras protein induces c-fos expression

  1987cited by this paper
• Altering gene expression with 5-azacytidine.

  1985cited by this paper
• Hypomethylation of DNA from benign and malignant human colon neoplasms.

  1985cited by this paper
• Deletion of the gag region from FBR murine osteosarcoma virus does not affect its enhanced transforming activity

  1985cited by this paper

• Epigenetic risk stratification in juvenile myelomonocytic leukemia by targeted methylation analysis of the BMP4 locus

  2025cites this paper
• DNMT1 expression partially dictates 5-Azacytidine sensitivity and correlates with RAS/MEK/ERK activity in gastric cancer cells

  2023cites this paper
• Silencing effects of mutant RAS signalling on transcriptomes.

  2022cites this paper
• Clinical and epigenetic features of colorectal cancer patients with somatic POLE proofreading mutations

  2021cites this paper
• Gene mutations do not operate in a vacuum: the increasing importance of epigenetics in juvenile myelomonocytic leukemia

  2019cites this paper
• Microarray Profiling of TGF-β1-Induced Long Non-Coding RNA Expression Patterns in Human Lung Bronchial Epithelial BEAS-2B Cells

  2018cites this paper
• A functional dissection of the relationships between BRAF, DNMT3B and the CpG island methylator phenotype in colorectal cancer

  2017cites this paper
• Basic studies on epigenetic carcinogenesis of low-dose exposure to 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) in vitro

  2017cites this paper
• Crk and CrkL are required for cell transformation by v‐fos and v‐ras

  2016cites this paper
• RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer

  2016cites this paper
• Epigenetic silencing of AKAP12 in juvenile myelomonocytic leukemia

  2016cites this paper
• Two for the Price of One: G Protein-Dependent and -Independent Functions of RGS6 In Vivo.

  2015cites this paper
• Regulator of G protein signaling 6 (RGS6), a multifarious and pleiotropic modulator of G protein coupled receptor signaling in brain

  2014cites this paper
• RGS6 suppresses Ras-induced cellular transformation by facilitating Tip60-mediated Dnmt1 degradation and promoting apoptosis

  2014cites this paper
• Epigenomic Characterization of Locally Advanced Anal Cancer: A Radiation Therapy Oncology Group 98-11 Specimen Study

  2014cites this paper
• Gravin gene expression in acute myeloid leukemia

  2013cites this paper
• Regulator of G protein signaling 6 is a novel suppressor of breast tumor initiation and progression.

  2013cites this paper
• Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer

  2013cites this paper
• Tumor and Stem Cell Biology Th-MYCN Mice with Caspase-8 De fi ciency Develop Advanced Neuroblastoma with Bone Marrow Metastasis

  2013cites this paper
• Th-MYCN mice with caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis.

  2013cites this paper
• Zac1 Regulates Astroglial Differentiation of Neural Stem Cells Through Socs3

  2013cites this paper
• We are what we Eat: How Nutritional Compounds Such as Isoflavones Shape Our Epigenome

  2011cites this paper
• Epigenetic modelling: DNA methylation and working towards model parameterisation

  2011cites this paper
• Global epigenetic profiling in bladder cancer.

  2011cites this paper
• Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia ( JMML ) with poor outcome

  2011cites this paper
• Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome.

  2011cites this paper
• Oncogenic Ras‐mediated downregulation of Clast1/LR8 is involved in Ras‐mediated neoplastic transformation and tumorigenesis in NIH3T3 cells

  2010cites this paper
• Biomarkers downstream of RAS: a search for robust transcriptional targets.

  2010cites this paper
• Emerging Roles for SSeCKS/Gravin/AKAP12 in the Control of Cell Proliferation, Cancer Malignancy, and Barriergenesis.

  2010cites this paper
• Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?

  2010cites this paper
• Analysis of 14-3-3σ methylation and associated changes in gene expression and function in colorectal carcinoma

  2010cites this paper
• RAF may induce cell proliferation through hypermethylation of tumor suppressor gene promoter in gastric epithelial cells

  2009cites this paper
• Microarray transfection analysis of conserved genomic sequences from three immediate early genes.

  2009cites this paper
• Epigenetic control

  2009cites this paper
• Silent Assassin: Oncogenic Ras Directs Epigenetic Inactivation of Target Genes

  2008cites this paper
• Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer.

  2008cites this paper
• Identificación de genes supresores tumorales regulados por CDC42 en cáncer colorrectal

  2008influential citation
• Anisomycin abrogates repression of protooncogene c‐fos transcription in E1A + cHa‐ras‐transformed cells through activation of MEK/ERK kinase cascade

  2008cites this paper
• DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment of CTCFL/BORIS and modulation of promoter histone methylation.

  2008cites this paper
• Podoplanin is a novel fos target gene in skin carcinogenesis.

  2008cites this paper
• Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer.

  2008cites this paper
• Functional transcriptomics: an experimental basis for understanding the systems biology for cancer cells.

  2007cites this paper
• Alteracions de la VIA RAS-RAF en càncer gastrointestinal amb defectes de reparació genòmica

  2007cites this paper
• oPOSSUM: integrated tools for analysis of regulatory motif over-representation

  2007cites this paper
• Methamphetamine alters expression of DNA methyltransferase 1 mRNA in rat brain.

  2007cites this paper
• Medulloblastomas derived from Cxcr6 mutant mice respond to treatment with a smoothened inhibitor.

  2007cites this paper
• AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies

  2007cites this paper
• LOT1 (ZAC1/PLAGL1) and its family members: Mechanisms and functions

  2007cites this paper
• Promoter-independent regulation of vimentin expression in mammary epithelial cells by val(12)ras and TGFbeta.

  2007cites this paper
• Transcription factors control invasion: AP-1 the first among equals

  2007cites this paper
• Deciphering AP-1 Function in Tumorigenesis: Fra-ternizing on Target Promoters

  2007cites this paper
• Cooperative DNA Binding with AP-1 Proteins Is Required for Transformation by EWS-Ets Fusion Proteins

  2006cites this paper
• RAS‐Mediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian surface epithelial cells

  2006cites this paper
• Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation

  2006cites this paper
• Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation.

  2006cites this paper
• Invasion is a genetic program regulated by transcription factors.

  2006cites this paper
• AP-1 Differentially Expressed Proteins Krp1 and Fibronectin Cooperatively Enhance Rho-ROCK-Independent Mesenchymal Invasion by Altering the Function, Localization, and Activity of Nondifferentially Expressed Proteins

  2006cites this paper
• De novo CpG island methylation in human cancer cells.

  2006cites this paper
• T Cell Deficiency Leads to Liver Carcinogenesis in Azoxymethane-Treated Rats

  2006cites this paper
• Shh pathway activity is down-regulated in cultured medulloblastoma cells: implications for preclinical studies.

  2006cites this paper
• Peroxisome proliferator-activated receptor gamma is a Zac target gene mediating Zac antiproliferation.

  2006cites this paper
• Global Effects of Ras Signaling on the Genetic Program in Mammalian Cells

  2006cites this paper
• [Cancer epigenetics].

  2006cites this paper
• CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

  2006cites this paper
• RAS and TGF-β exert antagonistic effects on extracellular matrix gene expression and fibroblast transformation

  2005cites this paper
• Functional analysis and secondary expression profiling of candidate genes deregulated in conjunction with oncogenic Ras signaling.

  2005cites this paper
• oPOSSUM: identification of over-represented transcription factor binding sites in co-expressed genes

  2005cites this paper
• A transcriptome map of cellular transformation by the fos oncogene

  2005cites this paper
• c-Jun interacts with phospholipids and c-Fos at the interface.

  2005cites this paper
• Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer

  2005cites this paper
• Cancer epigenetics.

  2005cites this paper
• The epigenome as a molecular marker and target

  2005cites this paper
• Otolith organ or semicircular canal stimulation induces c-fos expression in unipolar brush cells and granule cells of cat and squirrel monkey

  2005cites this paper
• The new field of epigenomics: implications for cancer and other common disease research.

  2004cites this paper
• Oncogene regulation of tumor suppressor genes in tumorigenesis.

  2004cites this paper